Technical Analysis for DVAX - Dynavax Technologies Corporation

Grade Last Price % Change Price Change
grade F 15.9 -0.31% -0.05
DVAX closed down 0.31 percent on Thursday, June 21, 2018, on 51 percent of normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical DVAX trend table...

Date Alert Name Type % Chg
Jun 21 Bollinger Band Squeeze Range Contraction 0.00%
Jun 20 Bollinger Band Squeeze Range Contraction -0.31%
Jun 19 Spinning Top Other 0.00%
Jun 19 Bollinger Band Squeeze Range Contraction 0.00%
Jun 18 Bollinger Band Squeeze Range Contraction -0.31%
Jun 18 Narrow Range Bar Range Contraction -0.31%
Jun 18 Inside Day Range Contraction -0.31%
Jun 15 Bollinger Band Squeeze Range Contraction -1.55%
Jun 14 Bearish Engulfing Bearish 0.00%
Jun 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%

Older signals for DVAX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. It develops product candidates based on the use of immunostimulatory sequences and immunoregulatory sequences. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The company also develops DV1179, a Phase I bifunctional inhibitor of TLR7 and TLR9 for the treatment of autoimmune and inflammatory diseases; and AZD1419, a preclinical drug candidate for the treatment of asthma. It has a strategic alliance with GlaxoSmithKline to discover, develop, and commercialize TLR inhibitors; and a research collaboration and license agreement with AstraZeneca AB for the discovery and development of TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is based in Berkeley, California.
Is DVAX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.45
52 Week Low 8.15
Average Volume 1,703,107
200-Day Moving Average 18.5099
50-Day Moving Average 17.2101
20-Day Moving Average 15.9825
10-Day Moving Average 15.96
Average True Range 0.712
ADX 19.86
+DI 17.87
-DI 22.69
Chandelier Exit (Long, 3 ATRs ) 14.914
Chandelier Exit (Short, 3 ATRs ) 16.836
Upper Bollinger Band 16.5493
Lower Bollinger Band 15.4157
Percent B (%b) 0.43
BandWidth 7.092758
MACD Line -0.3348
MACD Signal Line -0.413
MACD Histogram 0.0783
Fundamentals Value
Market Cap 871.94 Million
Num Shares 54.8 Million
EPS -2.42
Price-to-Earnings (P/E) Ratio -6.57
Price-to-Sales 143.85
Price-to-Book 7.89
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.50
Resistance 3 (R3) 16.53 16.37 16.40
Resistance 2 (R2) 16.37 16.21 16.35 16.37
Resistance 1 (R1) 16.13 16.12 16.05 16.10 16.33
Pivot Point 15.97 15.97 15.93 15.95 15.97
Support 1 (S1) 15.73 15.81 15.65 15.70 15.47
Support 2 (S2) 15.57 15.72 15.55 15.43
Support 3 (S3) 15.33 15.57 15.40
Support 4 (S4) 15.30